Capital Bank & Trust’s bluebird bio BLUE Stock Holding History

Capital Bank & Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-22	Closed	-$13K	–	339
2020 Q1	$13K	Sell	22 -54	-71%	-$52.6K	﹤0.01%	524
2019 Q4	$86K	Sell	76 -10,914	-99%	-$11.9M	﹤0.01%	380
2019 Q3	$13.1M	Buy	10,990 +4,802	+78%	+$7.33M	0.18%	101
2019 Q2	$10.2M	Buy	6,188 +2,151	+53%	+$3.72M	0.13%	119
2019 Q1	$8.23M	Buy	4,037 +632	+19%	+$1.11M	0.1%	122
2018 Q4	$4.38M	Sell	3,405 -10,196	-75%	-$15.6M	0.06%	143
2018 Q3	$25.7M	Sell	13,601 -68	-0.5%	-$140K	0.32%	85
2018 Q2	$27.8M	Buy	13,669 +339	+3%	+$773K	0.36%	83
2018 Q1	$29.5M	Buy	+13,330	New	+$33.9M	0.4%	82

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Bank & Trust's BLUE Position: Q2 2020 in Review

Capital Bank & Trust sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 22 shares — an estimated $13K sold.

Capital Bank & Trust first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $29.5M in Q1 2018. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

Capital Bank & Trust reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
Capital Bank & Trust sold 22 bluebird bio shares in Q2 2020, an estimated $13K.
Capital Bank & Trust first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
Capital Bank & Trust's bluebird bio position peaked at $29.5M in Q1 2018.
278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.